BioCorRx Inc. Director Kate DeVarney Resigns Effective Aug 31, 2026

What Happened
BioCorRx Inc. filed an 8-K (Item 5.02) on September 4, 2026 disclosing that Kate Beebe DeVarney, Ph.D. submitted her resignation from the company's board of directors, effective August 31, 2026. The filing states the resignation did not result from any disagreement with BioCorRx Inc. or its subsidiary BioCorRx Pharmaceuticals.

Key Details

• Date of resignation: August 31, 2026.
• 8-K filing date: September 4, 2026.
• Resignation did not arise from any disagreement with the Company or its subsidiary, BioCorRx Pharmaceuticals.
• The filing does not name a replacement or detail changes to board composition.

Why It Matters
A board member’s resignation is a governance event investors track because it can affect board quorum, committee membership, and oversight. This filing provides no indication of disputes or business issues (explicitly stating no disagreement), but investors should watch future disclosures for any appointment to replace Dr. DeVarney or updates on board structure.